Bifunctional Toxin DARP-LoPE Based on the Her2-Specific Innovative Module of a Non-Immunoglobulin Scaffold as a Promising Agent for Theranostics

G. M. Proshkina, D. V. Kiseleva, O. N. Shilova, A. V. Ryabova, E. I. Shramova, O. A. Stremovskiy, S. M. Deyev

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We have generated and characterized HER2-specific targeted toxin based on the low-immunogenic variant of Pseudomonas exotoxin A (LoPE), in which most of the human immunodominant B-cell epitopes have been inactivated. Nonimmunoglobulin DARPin-based HER2-specific protein was used as a targeting module for toxin delivery to the cellular target. Using confocal microscopy, it has been found that both domains in this hybrid toxin retained their functionality, i.e., the specific interaction with HER2 receptor, as well as the internalization and effective transport to ER typical of the wild-type Pseudomonas exotoxin A. The HER2-dependent cytotoxic effect correlated with receptor expression level at the cell surface, as shown in vitro using cell lines with different levels of HER2 expression. Due to the very high selective cytotoxicity against HER2-positive human tumor cells, as well as expected low immunogenicity, we believe that this new targeted toxin may be promising for future in vivo studies as a therapeutic agent for HER2-positive tumors.

Original languageEnglish
Pages (from-to)865-873
Number of pages9
JournalMolecular Biology
Volume51
Issue number6
DOIs
Publication statusPublished - 1 Nov 2017

Fingerprint

Immunotoxins
B-Lymphocyte Epitopes
Immunodominant Epitopes
Confocal Microscopy
Neoplasms
Cell Line
Proteins
Theranostic Nanomedicine
Pseudomonas aeruginosa toxA protein
Therapeutics
In Vitro Techniques

Keywords

  • DARPin
  • HER2
  • Pseudomonas exotoxin А
  • targeted therapy

ASJC Scopus subject areas

  • Biophysics
  • Structural Biology

Cite this

Bifunctional Toxin DARP-LoPE Based on the Her2-Specific Innovative Module of a Non-Immunoglobulin Scaffold as a Promising Agent for Theranostics. / Proshkina, G. M.; Kiseleva, D. V.; Shilova, O. N.; Ryabova, A. V.; Shramova, E. I.; Stremovskiy, O. A.; Deyev, S. M.

In: Molecular Biology, Vol. 51, No. 6, 01.11.2017, p. 865-873.

Research output: Contribution to journalArticle

Proshkina, G. M. ; Kiseleva, D. V. ; Shilova, O. N. ; Ryabova, A. V. ; Shramova, E. I. ; Stremovskiy, O. A. ; Deyev, S. M. / Bifunctional Toxin DARP-LoPE Based on the Her2-Specific Innovative Module of a Non-Immunoglobulin Scaffold as a Promising Agent for Theranostics. In: Molecular Biology. 2017 ; Vol. 51, No. 6. pp. 865-873.
@article{7648a9d256b54519aebc1ff111e50254,
title = "Bifunctional Toxin DARP-LoPE Based on the Her2-Specific Innovative Module of a Non-Immunoglobulin Scaffold as a Promising Agent for Theranostics",
abstract = "We have generated and characterized HER2-specific targeted toxin based on the low-immunogenic variant of Pseudomonas exotoxin A (LoPE), in which most of the human immunodominant B-cell epitopes have been inactivated. Nonimmunoglobulin DARPin-based HER2-specific protein was used as a targeting module for toxin delivery to the cellular target. Using confocal microscopy, it has been found that both domains in this hybrid toxin retained their functionality, i.e., the specific interaction with HER2 receptor, as well as the internalization and effective transport to ER typical of the wild-type Pseudomonas exotoxin A. The HER2-dependent cytotoxic effect correlated with receptor expression level at the cell surface, as shown in vitro using cell lines with different levels of HER2 expression. Due to the very high selective cytotoxicity against HER2-positive human tumor cells, as well as expected low immunogenicity, we believe that this new targeted toxin may be promising for future in vivo studies as a therapeutic agent for HER2-positive tumors.",
keywords = "DARPin, HER2, Pseudomonas exotoxin А, targeted therapy",
author = "Proshkina, {G. M.} and Kiseleva, {D. V.} and Shilova, {O. N.} and Ryabova, {A. V.} and Shramova, {E. I.} and Stremovskiy, {O. A.} and Deyev, {S. M.}",
year = "2017",
month = "11",
day = "1",
doi = "10.1134/S0026893317060140",
language = "English",
volume = "51",
pages = "865--873",
journal = "Molecular Biology",
issn = "0026-8933",
publisher = "Maik Nauka-Interperiodica Publishing",
number = "6",

}

TY - JOUR

T1 - Bifunctional Toxin DARP-LoPE Based on the Her2-Specific Innovative Module of a Non-Immunoglobulin Scaffold as a Promising Agent for Theranostics

AU - Proshkina, G. M.

AU - Kiseleva, D. V.

AU - Shilova, O. N.

AU - Ryabova, A. V.

AU - Shramova, E. I.

AU - Stremovskiy, O. A.

AU - Deyev, S. M.

PY - 2017/11/1

Y1 - 2017/11/1

N2 - We have generated and characterized HER2-specific targeted toxin based on the low-immunogenic variant of Pseudomonas exotoxin A (LoPE), in which most of the human immunodominant B-cell epitopes have been inactivated. Nonimmunoglobulin DARPin-based HER2-specific protein was used as a targeting module for toxin delivery to the cellular target. Using confocal microscopy, it has been found that both domains in this hybrid toxin retained their functionality, i.e., the specific interaction with HER2 receptor, as well as the internalization and effective transport to ER typical of the wild-type Pseudomonas exotoxin A. The HER2-dependent cytotoxic effect correlated with receptor expression level at the cell surface, as shown in vitro using cell lines with different levels of HER2 expression. Due to the very high selective cytotoxicity against HER2-positive human tumor cells, as well as expected low immunogenicity, we believe that this new targeted toxin may be promising for future in vivo studies as a therapeutic agent for HER2-positive tumors.

AB - We have generated and characterized HER2-specific targeted toxin based on the low-immunogenic variant of Pseudomonas exotoxin A (LoPE), in which most of the human immunodominant B-cell epitopes have been inactivated. Nonimmunoglobulin DARPin-based HER2-specific protein was used as a targeting module for toxin delivery to the cellular target. Using confocal microscopy, it has been found that both domains in this hybrid toxin retained their functionality, i.e., the specific interaction with HER2 receptor, as well as the internalization and effective transport to ER typical of the wild-type Pseudomonas exotoxin A. The HER2-dependent cytotoxic effect correlated with receptor expression level at the cell surface, as shown in vitro using cell lines with different levels of HER2 expression. Due to the very high selective cytotoxicity against HER2-positive human tumor cells, as well as expected low immunogenicity, we believe that this new targeted toxin may be promising for future in vivo studies as a therapeutic agent for HER2-positive tumors.

KW - DARPin

KW - HER2

KW - Pseudomonas exotoxin А

KW - targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=85038445208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038445208&partnerID=8YFLogxK

U2 - 10.1134/S0026893317060140

DO - 10.1134/S0026893317060140

M3 - Article

AN - SCOPUS:85038445208

VL - 51

SP - 865

EP - 873

JO - Molecular Biology

JF - Molecular Biology

SN - 0026-8933

IS - 6

ER -